MEDBOT-B Shares Surge Over 12% in Morning Trading Following Milestone Installation

Stock News07-03

Shares of MEDBOT-B (02252) experienced a significant rise of over 12% during the morning trading session. At the time of writing, the stock was up 12.53% to HK$26.22, with a turnover of HK$155 million.

The upward movement follows the company's recent announcement regarding its core product, the Toumai laparoscopic surgical robot. After surpassing 300 units in global commercial orders, the Toumai robot has now completed its 200th commercial installation worldwide at the HM Hospitales, a leading medical institution in Spain. All 200 installed units have received formal acceptance reports from the end customers.

The company stated that in overseas markets, the Toumai robot is rapidly expanding its global footprint across multiple regions. To date, it has been commercially installed and applied in over 60 countries and regions. Benefiting from this scale of commercial deployment and its leadership in remote surgery technology, the Toumai brand's influence is ranked among the top two globally.

Analysts have noted that since the second half of 2025, the company has transitioned from a "product introduction phase" into a "period of rapid order growth."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1140658861?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 11:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140658861","market":"other","top_or_hot":-1,"title":"MEDBOT-B Shares Surge Over 12% in Morning Trading Following Milestone Installation","media":"Stock News","content":"<p>Shares of <b>MEDBOT-B</b> (<b>02252</b>) experienced a significant rise of over 12% during the morning trading session. At the time of writing, the stock was up 12.53% to HK$26.22, with a turnover of HK$155 million.<br><br>The upward movement follows the company's recent announcement regarding its core product, the Toumai laparoscopic surgical robot. After surpassing 300 units in global commercial orders, the Toumai robot has now completed its 200th commercial installation worldwide at the HM Hospitales, a leading medical institution in Spain. All 200 installed units have received formal acceptance reports from the end customers.<br><br>The company stated that in overseas markets, the Toumai robot is rapidly expanding its global footprint across multiple regions. To date, it has been commercially installed and applied in over 60 countries and regions. Benefiting from this scale of commercial deployment and its leadership in remote surgery technology, the Toumai brand's influence is ranked among the top two globally.<br><br>Analysts have noted that since the second half of 2025, the company has transitioned from a \"product introduction phase\" into a \"period of rapid order growth.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDBOT-B Shares Surge Over 12% in Morning Trading Following Milestone Installation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDBOT-B Shares Surge Over 12% in Morning Trading Following Milestone Installation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-03 11:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>MEDBOT-B</b> (<b>02252</b>) experienced a significant rise of over 12% during the morning trading session. At the time of writing, the stock was up 12.53% to HK$26.22, with a turnover of HK$155 million.<br><br>The upward movement follows the company's recent announcement regarding its core product, the Toumai laparoscopic surgical robot. After surpassing 300 units in global commercial orders, the Toumai robot has now completed its 200th commercial installation worldwide at the HM Hospitales, a leading medical institution in Spain. All 200 installed units have received formal acceptance reports from the end customers.<br><br>The company stated that in overseas markets, the Toumai robot is rapidly expanding its global footprint across multiple regions. To date, it has been commercially installed and applied in over 60 countries and regions. Benefiting from this scale of commercial deployment and its leadership in remote surgery technology, the Toumai brand's influence is ranked among the top two globally.<br><br>Analysts have noted that since the second half of 2025, the company has transitioned from a \"product introduction phase\" into a \"period of rapid order growth.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1617","symbol_name":"AI医疗","start_time":0,"source_url":"","article_id":"1140658861","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140658861","pubTimestamp":1783048690,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of MEDBOT-B (02252) experienced a significant rise of over 12% during the morning trading session. At the time of writing, the stock was up 12.53% to HK$26.22, with a turnover of HK$155...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1617":"AI医疗","ROBO":"全球机器人自动化ETF-ROBO","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","BK4588":"碎股","02252":"微创机器人-B","VXUS":"国际股票ETF-Vanguard"},"translate_title":"里程碑安装后，MEDBOT-B股价早盘飙升超过12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"ROBO":1,"02252":1},"content_text":"Shares of MEDBOT-B (02252) experienced a significant rise of over 12% during the morning trading session. At the time of writing, the stock was up 12.53% to HK$26.22, with a turnover of HK$155 million.The upward movement follows the company's recent announcement regarding its core product, the Toumai laparoscopic surgical robot. After surpassing 300 units in global commercial orders, the Toumai robot has now completed its 200th commercial installation worldwide at the HM Hospitales, a leading medical institution in Spain. All 200 installed units have received formal acceptance reports from the end customers.The company stated that in overseas markets, the Toumai robot is rapidly expanding its global footprint across multiple regions. To date, it has been commercially installed and applied in over 60 countries and regions. Benefiting from this scale of commercial deployment and its leadership in remote surgery technology, the Toumai brand's influence is ranked among the top two globally.Analysts have noted that since the second half of 2025, the company has transitioned from a \"product introduction phase\" into a \"period of rapid order growth.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140658861","isCrawlerRequest":true}